GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (MIL:REC) » Definitions » Cyclically Adjusted PS Ratio

Recordati SpA (MIL:REC) Cyclically Adjusted PS Ratio : 6.11 (As of Jun. 01, 2025)


View and export this data going back to 1984. Start your Free Trial

What is Recordati SpA Cyclically Adjusted PS Ratio?

As of today (2025-06-01), Recordati SpA's current share price is €52.80. Recordati SpA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €8.64. Recordati SpA's Cyclically Adjusted PS Ratio for today is 6.11.

The historical rank and industry rank for Recordati SpA's Cyclically Adjusted PS Ratio or its related term are showing as below:

MIL:REC' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.17   Med: 6.81   Max: 10.01
Current: 6.11

During the past years, Recordati SpA's highest Cyclically Adjusted PS Ratio was 10.01. The lowest was 5.17. And the median was 6.81.

MIL:REC's Cyclically Adjusted PS Ratio is ranked worse than
83.74% of 738 companies
in the Drug Manufacturers industry
Industry Median: 2.12 vs MIL:REC: 6.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Recordati SpA's adjusted revenue per share data for the three months ended in Mar. 2025 was €3.252. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €8.64 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Recordati SpA Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Recordati SpA's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Cyclically Adjusted PS Ratio Chart

Recordati SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.25 9.31 5.36 6.31 6.04

Recordati SpA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.48 6.03 6.17 6.04 6.06

Competitive Comparison of Recordati SpA's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Recordati SpA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Cyclically Adjusted PS Ratio falls into.


;
;

Recordati SpA Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Recordati SpA's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=52.80/8.64
=6.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recordati SpA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Recordati SpA's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.252/122.5000*122.5000
=3.252

Current CPI (Mar. 2025) = 122.5000.

Recordati SpA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 1.263 100.279 1.543
201509 1.171 100.000 1.434
201512 1.262 99.814 1.549
201603 1.445 99.600 1.777
201606 1.367 99.900 1.676
201609 1.313 100.100 1.607
201612 1.392 100.300 1.700
201703 1.633 101.000 1.981
201706 1.478 101.100 1.791
201709 1.496 101.200 1.811
201712 1.551 101.200 1.877
201803 1.752 101.800 2.108
201806 1.576 102.400 1.885
201809 1.516 102.600 1.810
201812 1.623 102.300 1.943
201903 1.830 102.800 2.181
201906 1.723 103.100 2.047
201909 1.709 102.900 2.035
201912 1.825 102.800 2.175
202003 2.054 102.900 2.445
202006 1.583 102.900 1.885
202009 1.596 102.300 1.911
202012 1.698 102.600 2.027
202103 1.866 103.700 2.204
202106 1.820 104.200 2.140
202109 1.843 104.900 2.152
202112 2.030 106.600 2.333
202203 2.003 110.400 2.223
202206 2.265 112.500 2.466
202209 2.322 114.200 2.491
202212 2.273 119.000 2.340
202303 2.637 118.800 2.719
202306 2.356 119.700 2.411
202309 2.449 120.300 2.494
202312 2.515 119.700 2.574
202403 2.906 120.200 2.962
202406 2.765 120.700 2.806
202409 2.663 121.200 2.692
202412 2.865 121.200 2.896
202503 3.252 122.500 3.252

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Recordati SpA  (MIL:REC) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Recordati SpA Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA Business Description

Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.

Recordati SpA Headlines